BioVaxys Technology Corp. (BVAXF)
Market Closed
5 Dec, 20:00
OTC PINK OTC PINK Primary $
0. 15
-0.01
-3.91%
$
8.8M Market Cap
- P/E Ratio
4% Div Yield
25,350 Volume
- Eps
$ 0.16
Previous Close Day Range
0.14 0.16
Year Range
0.03 0.54
Want to track BVAXF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Sona Nanotech teams with BioVaxys on cancer tech – ICYMI
Sona Nanotech Inc earlier this week announced a research collaboration with BioVaxys to explore potential synergy between their respective cancer therapy technologies. The company said the agreement will focus on combining its targeted hyperthermia therapy (THT) with BioVaxys's DPX technology.
Proactiveinvestors | 7 months ago
Sona Nanotech and BioVaxys partner to develop novel cancer therapy
Sona Nanotech Inc (CSE:SONA, OTCQB:SNANF) is joining forces with BioVaxys Technology Corp. (CSE:BIOV, OTCQB:BVAXF) to explore a new approach to cancer treatment. The two companies are collaborating on research that brings together Sona's Targeted Hyperthermia Therapy (THT) and BioVaxys' DPX Immune Educating Platform, with the goal of developing a next-generation cancer therapy.
Proactiveinvestors | 7 months ago
2025 © Marketlog. All Rights Reserved.
